{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T01:30:27Z","timestamp":1778981427978,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T00:00:00Z","timestamp":1236643200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1745-6215-10-16","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T19:10:43Z","timestamp":1236712243000},"source":"Crossref","is-referenced-by-count":21,"title":["New therapeutic approach to Tourette Syndrome in children based on a randomized placebo-controlled double-blind phase IV study of the effectiveness and safety of magnesium and vitamin B6"],"prefix":"10.1186","volume":"10","author":[{"given":"Rafael","family":"Garcia-Lopez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Perea-Milla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar Ruiz","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Rivas-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Romero-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose L","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Faus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guadalupe del Castillo","family":"Aguas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C Ramos","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,10]]},"reference":[{"key":"304_CR1","first-page":"369","volume":"85","author":"JF Leckman","year":"2001","unstructured":"Leckman JF, Cohen DJ, Goetz CG, Jankovic J: Tourette syndrome: pieces of the puzzle. Adv Neurol. 2001, 85: 369-390.","journal-title":"Adv Neurol"},{"key":"304_CR2","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1056\/NEJMra010032","volume":"345","author":"J Jankovic","year":"2001","unstructured":"Jankovic J: Tourette's syndrome. N Engl J Med. 2001, 345: 1184-1192. 10.1056\/NEJMra010032.","journal-title":"N Engl J Med"},{"key":"304_CR3","first-page":"15","volume":"85","author":"J Jankovic","year":"2001","unstructured":"Jankovic J: Differential diagnosis and etiology of tics. Adv Neurol. 2001, 85: 15-29.","journal-title":"Adv Neurol"},{"key":"304_CR4","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1212\/WNL.44.4.699","volume":"44","author":"R Kurlan","year":"1994","unstructured":"Kurlan R, Whitmore D, Irvine C, McDermontt MP, Como PG: Tourette's syndrome in a special education population: a pilot study involving a single school district. Neurology. 1994, 44: 699-702.","journal-title":"Neurology"},{"key":"304_CR5","first-page":"131","volume":"25","author":"R Jin","year":"2004","unstructured":"Jin R, Zheng RY, Huang WW, Xu HQ, Shao P, Chen H, Zou YL, Huang HB, Zou Cl, Zhou ZM: Study on the prevalence of Tourette syndrome in children and juveniles aged 7\u201316 years in Wenzhou area. Zhonghua Liu Xing Bing Xue Za Zhi. 2004, 25: 131-133.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"304_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1469-8749.2003.tb00402.x","volume":"45","author":"N Khalifa","year":"2003","unstructured":"Khalifa N, von Knorring AL: Prevalence of tic disorders and Tourette syndrome in a Swedish school population. Dev Med Child Neurol. 2003, 45: 315-319. 10.1017\/S0012162203000598.","journal-title":"Dev Med Child Neurol"},{"key":"304_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0022-3999(02)00580-9","volume":"55","author":"MM Robertson","year":"2003","unstructured":"Robertson MM: Diagnosing Tourette syndrome: is it a common disorder?. J Psychosom Res. 2003, 55: 3-6. 10.1016\/S0022-3999(02)00580-9.","journal-title":"J Psychosom Res"},{"key":"304_CR8","doi-asserted-by":"crossref","unstructured":"A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. The Tourette Syndrome Association International Consortium for Genetics. Am J Hum Genet. 1999, 65: 1428-1436. 10.1086\/302613.","DOI":"10.1086\/302613"},{"key":"304_CR9","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1177\/08830738060210081101","volume":"21","author":"D Keen-Kim","year":"2006","unstructured":"Keen-Kim D, Freimer NB: Genetics and epidemiology of Tourette syndrome. J Child Neurol. 2006, 21: 665-671. 10.1177\/08830738060210081101.","journal-title":"J Child Neurol"},{"key":"304_CR10","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1097\/chi.0b013e318068fbcc","volume":"46","author":"JE Swain","year":"2007","unstructured":"Swain JE, Scahill L, Lombroso PJ, King RA, Leckman JF: Tourette syndrome and tic disorders: a decade of progress. J Am Acad Child Adolesc Psychiatry. 2007, 46: 947-968. 10.1097\/chi.0b013e318068fbcc.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"304_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/00004583-199901000-00024","volume":"38","author":"M Ernst","year":"1999","unstructured":"Ernst M, Zametkin AJ, Jons PH, Matochik JA, Pascualvaca D, Cohen RM: High presynaptic dopaminergic activity in children with Tourette's disorder. J Am Acad Child Adolesc Psychiatry. 1999, 38: 86-94. 10.1097\/00004583-199901000-00024.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"304_CR12","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.33588\/rn.46S01.2008014","volume":"46","author":"JO Cornelio-Nieto","year":"2008","unstructured":"Cornelio-Nieto JO: The neurobiology of Tourette syndrome. Rev Neurol. 2008, 46: S21-S23.","journal-title":"Rev Neurol"},{"issue":"1","key":"304_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jpsychires.2008.01.014","volume":"43","author":"M Ferrari","year":"2008","unstructured":"Ferrari M, Termine C, Franciotta D, Castiglioni E, Pagani A, Lanzi G, Marino F, Lecchini S, Cosentino M, Balottin U: Dopaminergic receptor D5 mRNA expression is increased in circulating lymphocytes of Tourette syndrome patients. J Psychiatr Res. 2008, 43 (1): 24-9. 10.1016\/j.jpsychires.2008.01.014.","journal-title":"J Psychiatr Res"},{"key":"304_CR14","first-page":"179","volume":"85","author":"BS Peterson","year":"2001","unstructured":"Peterson BS: Neuroimaging studies of Tourette syndrome: a decade of progress. Adv Neurol. 2001, 85: 179-196.","journal-title":"Adv Neurol"},{"key":"304_CR15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jphysparis.2006.03.004","volume":"99","author":"A Laihinen","year":"2006","unstructured":"Laihinen A, Halsband U: PET imaging of the basal ganglia. J Physiol Paris. 2006, 99: 406-413. 10.1016\/j.jphysparis.2006.03.004.","journal-title":"J Physiol Paris"},{"key":"304_CR16","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1176\/appi.ajp.159.8.1329","volume":"159","author":"HS Singer","year":"2002","unstructured":"Singer HS, Szymanski S, Giuliano J, Yokoi F, Dogan AS, Brasic JR, Zhou Y, Grace AA, Wong DF: Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET. Am J Psychiatry. 2002, 159: 1329-1336. 10.1176\/appi.ajp.159.8.1329.","journal-title":"Am J Psychiatry"},{"key":"304_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.pscychresns.2007.04.006","volume":"162","author":"WJ Hwang","year":"2008","unstructured":"Hwang WJ, Yao WJ, Fu YK, Yang AS: [99mTc]TRODAT-1\/[123I]IBZM SPECT studies of the dopaminergic system in Tourette syndrome. Psychiatry Res. 2008, 162: 159-166. 10.1016\/j.pscychresns.2007.04.006.","journal-title":"Psychiatry Res"},{"key":"304_CR18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1177\/08830738060210091401","volume":"21","author":"P Pavone","year":"2006","unstructured":"Pavone P, Parano E, Rizzo R, Trifiletti RR: Autoimmune neuropsychiatric disorders associated with streptococcal infection: Sydenham chorea, PANDAS, and PANDAS variants. J Child Neurol. 2006, 21: 727-736. 10.1177\/08830738060210091401.","journal-title":"J Child Neurol"},{"key":"304_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/107424840100600306","volume":"6","author":"B Drolet","year":"2001","unstructured":"Drolet B, Rousseau G, Daleau P, Cardinal R, Simard C, Turgeon J: Pimozide (Orap) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current in native cardiac myocytes. J Cardiovasc Pharmacol Ther. 2001, 6: 255-260. 10.1177\/107424840100600306.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"304_CR20","first-page":"129","volume":"57","author":"RR Silva","year":"1996","unstructured":"Silva RR, Munoz DM, Daniel W, Barickman J, Friedhoff AJ: Causes of haloperidol discontinuation in patients with Tourette's disorder: management and alternatives. J Clin Psychiatry. 1996, 57: 129-135.","journal-title":"J Clin Psychiatry"},{"key":"304_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0022-3999(03)00060-6","volume":"55","author":"P Sandor","year":"2003","unstructured":"Sandor P: Pharmacological management of tics in patients with TS. J Psychosom Res. 2003, 55: 41-48. 10.1016\/S0022-3999(03)00060-6.","journal-title":"J Psychosom Res"},{"key":"304_CR22","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1176\/ajp.154.8.1057","volume":"154","author":"FR Sallee","year":"1997","unstructured":"Sallee FR, Nesbitt L, Jackson C, Sine L, Sethuraman G: Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder. Am J Psychiatry. 1997, 154: 1057-1062.","journal-title":"Am J Psychiatry"},{"key":"304_CR23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/00004583-200402000-00017","volume":"43","author":"DL Gilbert","year":"2004","unstructured":"Gilbert DL, Batterson JR, Sethuraman G, Sallee FR: Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial. J Am Acad Child Adolesc Psychiatry. 2004, 43: 206-214. 10.1097\/00004583-200402000-00017.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"304_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1212\/WNL.58.4.527","volume":"58","author":"Tourett's Syndrome Study Group","year":"2002","unstructured":"Tourett's Syndrome Study Group: Treatment of ADHD in children with tics: a randomized controlled trial. Neurology. 2002, 58: 527-536.","journal-title":"Neurology"},{"key":"304_CR25","first-page":"946","volume":"151","author":"E Gatto","year":"1994","unstructured":"Gatto E, Pikielny R, Micheli F: Fluoxetine in Tourette's syndrome. Am J Psychiatry. 1994, 151: 946-947.","journal-title":"Am J Psychiatry"},{"key":"304_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/da.20197","volume":"23","author":"EA Storch","year":"2006","unstructured":"Storch EA, Larson MJ, Shapira NA, Ward HE, Murphy TK, Geffken GR, Valerio H, Goodman WKl: Clinical predictors of early fluoxetine treatment response in obsessive-compulsive disorder. Depress Anxiety. 2006, 23: 429-433. 10.1002\/da.20197.","journal-title":"Depress Anxiety"},{"key":"304_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1054\/mehy.2001.1447","volume":"58","author":"BL Grimaldi","year":"2002","unstructured":"Grimaldi BL: The central role of magnesium deficiency in Tourette's syndrome: causal relationships between magnesium deficiency, altered biochemical pathways and symptoms relating to Tourette's syndrome and several reported comorbid conditions. Med Hypotheses. 2002, 58: 47-60. 10.1054\/mehy.2001.1447.","journal-title":"Med Hypotheses"},{"key":"304_CR28","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0890-8567(09)63722-9","volume":"34","author":"DE Comings","year":"1995","unstructured":"Comings DE: DSM-IV criteria for Tourette's. J Am Acad Child Adolesc Psychiatry. 1995, 34: 401-402.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"304_CR29","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","volume":"28","author":"JF Leckman","year":"1989","unstructured":"Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ: The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989, 28: 566-573. 10.1097\/00004583-198907000-00015.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"304_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF00435974","volume":"5","author":"X Badia","year":"1996","unstructured":"Badia X, Gutierrez F, Wiklund I, Alonso J: Validity and reliability of the Spanish version of the Psychological General Well-Being Index. Qual Life Res. 1996, 5: 101-108. 10.1007\/BF00435974.","journal-title":"Qual Life Res"},{"key":"304_CR31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.33588\/rn.4605.2007481","volume":"46","author":"R Garcia-Lopez","year":"2008","unstructured":"Garcia-Lopez R, Perea-Milla E, Romero-Gonzalez J, Rivas-Ruiz F, Ruiz-Garcia C, Oviedo-Joekes E, de Las Mulas-Bejar M: [Spanish adaptation and diagnostic validity of the Yale Global Tics Severity Scale]. Rev Neurol. 2008, 46: 261-266.","journal-title":"Rev Neurol"},{"key":"304_CR32","volume-title":"Assessment of quality of life in clinical trials of cardiovascular therapies","author":"HJ Dupuy","year":"1984","unstructured":"Dupuy HJ: The psychological general well-being index. Assessment of quality of life in clinical trials of cardiovascular therapies. Edited by: Wegner NK MMFCe. 1984, New York: Le Jacq"},{"key":"304_CR33","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1136\/bmj.329.7479.1356","volume":"329","author":"U Chowdhury","year":"2004","unstructured":"Chowdhury U, Heyman I: Tourette's syndrome in children. BMJ. 2004, 329: 1356-1357. 10.1136\/bmj.329.7479.1356.","journal-title":"BMJ"},{"key":"304_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4088\/JCP.v62n0111","volume":"62","author":"R Bruggeman","year":"2001","unstructured":"Bruggeman R, van der LC, Buitelaar JK, Gericke GS, Hawkridge SM, Temlett JA: Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study. J Clin Psychiatry. 2001, 62: 50-56.","journal-title":"J Clin Psychiatry"},{"key":"304_CR35","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1097\/01.CHI.0000046897.27264.46","volume":"42","author":"FR Sallee","year":"2003","unstructured":"Sallee FR, Gilbert DL, Vinks AA, Miceli JJ, Robarge L, Wilner K: Pharmacodynamics of ziprasidone in children and adolescents: impact on dopamine transmission. J Am Acad Child Adolesc Psychiatry. 2003, 42: 902-907. 10.1097\/01.CHI.0000046897.27264.46.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"304_CR36","first-page":"245","volume":"58","author":"CG Goetz","year":"1992","unstructured":"Goetz CG: and clonazepam in Tourette syndrome. Adv Neurol. 1992, 58: 245-251.","journal-title":"Adv Neurol"},{"key":"304_CR37","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/mds.21615","volume":"22","author":"CL Smith-Hicks","year":"2007","unstructured":"Smith-Hicks CL, Bridges DD, Paynter NP, Singer HS: A double blind randomized placebo control trial of levetiracetam in tourette syndrome. Mov Disord. 2007, 22: 1764-1770. 10.1002\/mds.21615.","journal-title":"Mov Disord"},{"key":"304_CR38","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/0269881105049042","volume":"19","author":"L Scahill","year":"2005","unstructured":"Scahill L, Blair J, Leckman JF, Martin A: Sudden death in a patient with Tourette syndrome during a clinical trial of ziprasidone. J Psychopharmacol. 2005, 19: 205-206. 10.1177\/0269881105049042.","journal-title":"J Psychopharmacol"},{"key":"304_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/cap.2000.10.27","volume":"10","author":"FR Sallee","year":"2000","unstructured":"Sallee FR, DeVane CL, Ferrell RE: Fluoxetine-related death in a child with cytochrome P-450 2D6 genetic deficiency. J Child Adolesc Psychopharmacol. 2000, 10: 27-34. 10.1089\/cap.2000.10.27.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"304_CR40","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1136\/jnnp.2006.104067","volume":"79","author":"D Servello","year":"2008","unstructured":"Servello D, Porta M, Sassi M, Brambilla A, Robertson MM: Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation. J Neurol Neurosurg Psychiatry. 2008, 79: 136-142. 10.1136\/jnnp.2006.104067.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"304_CR41","first-page":"392","volume":"26","author":"S Ma","year":"2006","unstructured":"Ma S, Liu XY, Yu RL, Chen LJ: Clinical observation on acupuncture for treatment of Tourette's syndrome. Zhongguo Zhen Jiu. 2006, 26: 392-394.","journal-title":"Zhongguo Zhen Jiu"},{"key":"304_CR42","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.parkreldis.2007.10.007","volume":"14","author":"M Aguirregomozcorta","year":"2008","unstructured":"Aguirregomozcorta M, Pagonabarraga J, Diaz-Manera J, Pascual-Sedano B, Gironell A, Kulisevsky J: Efficacy of botulinum toxin in severe Tourette syndrome with dystonic tics involving the neck. Parkinsonism Relat Disord. 2008, 14: 443-445. 10.1016\/j.parkreldis.2007.10.007.","journal-title":"Parkinsonism Relat Disord"},{"key":"304_CR43","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S0140-6736(98)12297-3","volume":"354","author":"SJ Perlmutter","year":"1999","unstructured":"Perlmutter SJ, Leitman SF, Garvey MA, Hamburger S, Feldman E, Leonard HL, Swedo SE: Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet. 1999, 354: 1153-1158. 10.1016\/S0140-6736(98)12297-3.","journal-title":"Lancet"},{"key":"304_CR44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bbr.2007.07.040","volume":"186","author":"X Liu","year":"2008","unstructured":"Liu X, Wang Y, Li D, Ju X: Transplantation of rat neural stem cells reduces stereotypic behaviors in rats after intrastriatal microinfusion of Tourette syndrome sera. Behav Brain Res. 2008, 186: 84-90. 10.1016\/j.bbr.2007.07.040.","journal-title":"Behav Brain Res"},{"key":"304_CR45","first-page":"58","volume":"106","author":"AD Anichkov","year":"2006","unstructured":"Anichkov AD, Meliucheva LA, Obliapin AV, Plotnikova IV, Poliakov I, Kholiavin AI, Medvedev SV: The experience in surgical treatment of Gilles de la Tourette's syndrome. Zh Nevrol Psikhiatr Im S S Korsakova. 2006, 106: 58-61.","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"304_CR46","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1086\/302199","volume":"64","author":"IC Meij","year":"1999","unstructured":"Meij IC, Saar K, Heuvel van den LP, Nuernberg G, Vollmer M, Hildebrandt F, Reis A, Monnens LA, Knoers NV: Hereditary isolated renal magnesium loss maps to chromosome 11q23. Am J Hum Genet. 1999, 64: 180-188. 10.1086\/302199.","journal-title":"Am J Hum Genet"},{"key":"304_CR47","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1017\/S0033291700037880","volume":"26","author":"H Rickards","year":"1996","unstructured":"Rickards H, Dursun SM, Farrar G, Betts T, Corbett JA, Handley SL: Increased plasma kynurenine and its relationship to neopterin and tryptophan in Tourette's syndrome. Psychol Med. 1996, 26: 857-862.","journal-title":"Psychol Med"},{"key":"304_CR48","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1080\/07315724.1997.10718697","volume":"16","author":"E Planells","year":"1997","unstructured":"Planells E, Lerma A, Sanchez-Morito N, Aranda P, Llopis J: Effect of magnesium deficiency on vitamina B2 and B6 status in the rat. J Am Coll Nutr. 1997, 16: 352-356.","journal-title":"J Am Coll Nutr"},{"key":"304_CR49","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0920-1211(94)90055-8","volume":"17","author":"M Nakamura","year":"1997","unstructured":"Nakamura M, Abe S, Goto Y, Chishaki A, Akazawa K, Kato M: In vivo assessment of prevention of white-noise-induced seizure in magnesium-deficient rats by N-methyl-D-aspartate receptor blockers. Epilepsy Res. 1997, 17: 249-256. 10.1016\/0920-1211(94)90055-8.","journal-title":"Epilepsy Res"},{"key":"304_CR50","first-page":"3","volume":"9","author":"WB Weglicki","year":"1996","unstructured":"Weglicki WB, Dickens BF, Wagner TL, Chimielinska JJ, Phillips TM: Immunoregulation by neuropeptides in magnesium deficiency: ex vivo effect of enhanced substance P production on circulating T lymphocytes from magnesium-deficient mice. Magnes Res. 1996, 9: 3-11.","journal-title":"Magnes Res"},{"key":"304_CR51","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.2741\/1316","volume":"9","author":"R Touyz","year":"2004","unstructured":"Touyz R: Magnesium in clinical medicine. Front Biosci. 2004, 9: 1278-1293. 10.2741\/1316.","journal-title":"Front Biosci"},{"key":"304_CR52","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/BF01800664","volume":"8","author":"B Fowler","year":"1985","unstructured":"Fowler B: Recent advances in the mechanism of pyridoxine-responsive disorders. J Inherit Metab Dis. 1985, 8: 76-83. 10.1007\/BF01800664.","journal-title":"J Inherit Metab Dis"},{"key":"304_CR53","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1515\/CCLM.1999.075","volume":"37","author":"HJ Huijgen","year":"1999","unstructured":"Huijgen HJ, Sanders R, Cecco SA, Rehak NN, Sanders GT, Elin RJ: Serum ionized magnesium: comparison of results obtained with three ion-selective analyzers. Clin Chem Lab Med. 1999, 37: 465-470. 10.1515\/CCLM.1999.075.","journal-title":"Clin Chem Lab Med"},{"issue":"18","key":"304_CR54","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1157\/13129113","volume":"131","author":"R Garcia-Lopez","year":"2008","unstructured":"Garcia-Lopez R, Romero-Gonzalez J, Perea-Milla E, Ruiz-Garcia C, Rivas-Ruiz F, de las Mulas Bejar M: An open study evaluating the efficacy and security of magnesium and vitamin B6 as a treatment of Tourette syndrome in children. Med Clin (Barc). 2008, 131 (18): 689-692. 10.1157\/13129113.","journal-title":"Med Clin (Barc)"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1745-6215-10-16\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-10-16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-10-16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-10-16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T06:09:32Z","timestamp":1738994972000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-10-16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,10]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["304"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-10-16","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,10]]},"article-number":"16"}}